Aditxt Inc. (NASDAQ: ADTX), a social innovation platform focused on accelerating health innovations, announced it will implement a 1-for-27 reverse stock split of its common stock, effective at the opening of trading on the Nasdaq Capital Market on May 18, 2026. The reverse split is intended to bring the company into compliance with Nasdaq’s minimum bid price requirement, reducing outstanding common shares from approximately 13.8 million to about 510,123, with the stock continuing to trade under the symbol ADTX.
The decision to consolidate shares comes as Aditxt seeks to maintain its listing on the Nasdaq exchange, which requires a minimum bid price of $1.00 per share. By reducing the number of shares outstanding, the company aims to boost the per-share price, thereby satisfying the listing standard. The reverse stock split will affect all shareholders proportionally, meaning the overall value of their holdings will remain unchanged immediately after the split, excluding any rounding adjustments.
Aditxt operates as a social innovation platform that accelerates promising health innovations by collaborating with research institutions, industry partners, and shareholders. The company’s mission is to “Make Promising Innovations Possible Together” through a model that democratizes innovation and empowers collective progress. Aditxt currently runs four programs focused on autoimmunity, cancer and early disease detection, infectious diseases, and women’s health.
The reverse split is a common strategy for companies facing delisting risk due to low share prices. While it does not change the company’s fundamental value, it can improve the stock’s perception among investors and ensure continued listing on a major exchange. Aditxt’s stock has faced pressure recently, and the split is seen as a necessary step to regain compliance. For more details on the reverse split and the company’s programs, visit the full press release.
Investors can stay updated on Aditxt’s latest news and developments through the company’s newsroom. The reverse split underscores Aditxt’s commitment to maintaining its public listing as it continues to advance its pipeline of health innovations.
